Company / Free Cash Flow per Share
X4 Pharmaceuticals, Inc Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$16.95
FY2025
5-year range
-$16.95 / -$0.46
FY2021-FY2025
Trend
-3575.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share changed -3575% YoY in FY2025, a notable deviation from the 5-year average annual change of -712%.
Based on SEC 10-K filings.
-16.95 in FY2025.
Declined from $-2.14 to $-16.95 over the past 3 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 3575.5% year-over-year.
- Peak free cash flow per share was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.53 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$16.95 | -3575.5% |
| FY2024 | -$0.46 | +78.4% |
| FY2022 | -$2.14 | +27.7% |
| FY2021 | -$2.96 | -87.7% |
| FY2020 | -$1.58 | -3.8% |
| FY2018 | -$1.52 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026